-
Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP.
Hum Mol Genet. 2005 Sep 15;14(18):2717-26
PMID: 16087682
-
Mechanisms of Disease: advances in diagnosis and treatment of hyperinsulinism in neonates.
Nat Clin Pract Endocrinol Metab. 2007 Jan;3(1):57-68
PMID: 17179930
-
A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications.
Diabetologia. 2008 May;51(5):802-10
PMID: 18335204
-
Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.
Pflugers Arch. 2006 Dec;453(3):323-32
PMID: 17021801
-
A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels.
Neuron. 1999 Mar;22(3):537-48
PMID: 10197533
-
Infantile spasms as an epileptic feature of DEND syndrome associated with an activating mutation in the potassium adenosine triphosphate (ATP) channel, Kir6.2.
J Child Neurol. 2007 Sep;22(9):1147-50
PMID: 17890419
-
Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy.
Diabetes. 1998 Jul;47(7):1145-51
PMID: 9648840
-
Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification.
Nat Neurosci. 2005 Mar;8(3):279-87
PMID: 15723059
-
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
N Engl J Med. 2006 Aug 3;355(5):467-77
PMID: 16885550
-
Functional analysis of a structural model of the ATP-binding site of the KATP channel Kir6.2 subunit.
EMBO J. 2005 Jan 26;24(2):229-39
PMID: 15650751
-
Regulation of KATP channel activity by diazoxide and MgADP. Distinct functions of the two nucleotide binding folds of the sulfonylurea receptor.
J Gen Physiol. 1997 Dec;110(6):643-54
PMID: 9382893
-
The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide.
EMBO J. 1997 Mar 17;16(6):1145-52
PMID: 9135131
-
Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects.
Diabetes. 2006 Jun;55(6):1705-12
PMID: 16731833
-
Crystal structure of a Kir3.1-prokaryotic Kir channel chimera.
EMBO J. 2007 Sep 5;26(17):4005-15
PMID: 17703190
-
KATP channels as molecular sensors of cellular metabolism.
Nature. 2006 Mar 23;440(7083):470-6
PMID: 16554807
-
Burst kinetics of single calcium-activated potassium channels in cultured rat muscle.
J Physiol. 1983 Nov;344:605-23
PMID: 6317854
-
Hyperinsulinism in infancy: from basic science to clinical disease.
Physiol Rev. 2004 Jan;84(1):239-75
PMID: 14715916
-
An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.
Diabetes. 2007 Feb;56(2):328-36
PMID: 17259376
-
The kinetic and physical basis of K(ATP) channel gating: toward a unified molecular understanding.
Biophys J. 2000 May;78(5):2334-48
PMID: 10777731
-
A novel method for measurement of submembrane ATP concentration.
J Biol Chem. 2000 Sep 29;275(39):30046-9
PMID: 10866996
-
The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy.
J Clin Endocrinol Metab. 2008 Mar;93(3):1054-61
PMID: 18073297
-
Adenosine diphosphate as an intracellular regulator of insulin secretion.
Science. 1996 Jun 21;272(5269):1785-7
PMID: 8650576
-
A novel KCNJ11 mutation associated with congenital hyperinsulinism reduces the intrinsic open probability of beta-cell ATP-sensitive potassium channels.
J Biol Chem. 2006 Feb 3;281(5):3006-12
PMID: 16332676
-
Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy.
Diabetes. 2005 Sep;54(9):2503-13
PMID: 16123337
-
Triggering and amplifying pathways of regulation of insulin secretion by glucose.
Diabetes. 2000 Nov;49(11):1751-60
PMID: 11078440
-
Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels: identification and rescue.
Diabetes. 2007 Sep;56(9):2339-48
PMID: 17575084
-
Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism.
Hum Mutat. 2009 Feb;30(2):170-80
PMID: 18767144
-
Activation and inhibition of K-ATP currents by guanine nucleotides is mediated by different channel subunits.
Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8872-7
PMID: 9238070
-
Targeted overactivity of beta cell K(ATP) channels induces profound neonatal diabetes.
Cell. 2000 Mar 17;100(6):645-54
PMID: 10761930
-
The Walter B. Cannon Physiology in Perspective Lecture, 2007. ATP-sensitive K+ channels and disease: from molecule to malady.
Am J Physiol Endocrinol Metab. 2007 Oct;293(4):E880-9
PMID: 17652156
-
MgATP activates the beta cell KATP channel by interaction with its SUR1 subunit.
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):7185-90
PMID: 9618560
-
A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome.
EMBO Rep. 2005 May;6(5):470-5
PMID: 15864298
-
Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor.
Nature. 1997 May 8;387(6629):179-83
PMID: 9144288